Bright Minds Biosciences (DRUG) Free Cash Flow: 2019-2021

Historic Free Cash Flow for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to -$9.7 million.

  • Bright Minds Biosciences' Free Cash Flow fell 3441.42% to -$9.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$5.8 million, marking a year-over-year change of. This contributed to the annual value of -$1.4 million for FY2024, which is 73.89% up from last year.
  • As of Q3 2021, Bright Minds Biosciences' Free Cash Flow stood at -$9.7 million, which was down 502.36% from $2.4 million recorded in Q2 2021.
  • Bright Minds Biosciences' Free Cash Flow's 5-year high stood at $2.4 million during Q2 2021, with a 5-year trough of -$9.7 million in Q3 2021.
  • Its 3-year average for Free Cash Flow is -$1.0 million, with a median of $194,842 in 2019.
  • Data for Bright Minds Biosciences' Free Cash Flow shows a maximum YoY crashed of 3,441.42% (in 2021) over the last 5 years.
  • Quarterly analysis of 3 years shows Bright Minds Biosciences' Free Cash Flow stood at -$31,827 in 2019, then slumped by 763.32% to $421,510 in 2020, then plummeted by 3,441.42% to -$9.7 million in 2021.
  • Its Free Cash Flow was -$9.7 million in Q3 2021, compared to $2.4 million in Q2 2021 and $1.1 million in Q1 2021.